Dingdang Medicine Express, a Chinese online drug retail platform, has secured a RMB600 million (US$89.13 million) series B round of financing, according to a statement released on Thursday.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!Register Now
Already have an account or paid subscription?